In addition to targeting adaptive immune checkpoints for multiple metastatic and treatment-refractory cancers, recent studies have shown that innate immune checkpoint CD47 is critical for cancer cells to escape from immune surveillance such as macrophage attack and phagocytes [85,86]. Here, CD47 is linked to cancer.